2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T4f61,

Summary Table

Category	Details
Risk Factors	Children aged 2-12, women (especially during menstruation or pregnancy), migraine history, poor ventilation in vehicles, reading while in motion, individuals with high vestibular sensitivity
Etiology	Sensory mismatch between the vestibular system, visual input, and proprioceptive signals
Patient Presentation	Nausea, vomiting, dizziness, cold sweating, and general malaise triggered by passive motion (car, boat, plane, amusement rides)
Classic Physical Exam	Pallor, diaphoresis, increased salivation, no focal neurological deficits, no nystagmus at rest
Key Diagnostic Results	Clinical diagnosis; no labs or imaging required. Workup only needed if atypical features suggest an alternative etiology
Management	First-line prophylaxis: Scopolamine transdermal patch. Acute/short-duration: Dimenhydrinate or meclizine. Non-pharmacologic: Gaze fixation on the horizon, adequate ventilation, seat positioning
Keywords	"Nausea and vomiting during travel," "sensory conflict," "symptoms resolve after motion stops," "child vomiting in the car," "seasickness"

1. Pathophysiology

Motion sickness arises from a sensory conflict within the central nervous system. Under normal conditions, the brain integrates three streams of spatial information: the vestibular apparatus (semicircular canals and otolith organs detecting angular and linear acceleration), the visual system (perceiving movement relative to the environment), and proprioceptors (muscles and joints sensing body position). When these inputs are congruent, spatial orientation is maintained without difficulty.

The problem begins when these signals become discordant. A classic scenario is reading a book inside a moving car. The vestibular system detects acceleration and turns, but the visual system is locked on a stationary page and reports no movement. The proprioceptors, meanwhile, confirm the body is seated and still. This three-way mismatch is interpreted by the vestibular nuclei in the brainstem as a conflict state.

The brainstem responds by activating the chemoreceptor trigger zone (CTZ) in the area postrema and the vomiting center in the medulla. This triggers a cascade of autonomic symptoms: nausea, vomiting, pallor, diaphoresis, and increased salivation. The key neurotransmitters involved are acetylcholine (muscarinic, M1) acting on the vestibular nuclei and vomiting center, and histamine (H1) acting on the CTZ and vestibular pathways. This is why anticholinergics and antihistamines are the pharmacologic backbone of treatment.

Notably, the driver of a vehicle is far less susceptible than passengers. This is because the driver's brain can predict upcoming motion through active motor commands, reducing the sensory mismatch. This observation is a frequently tested concept that reinforces the conflict theory.

Habituation is a well-documented phenomenon: repeated exposure to the provocative motion over days leads to gradual desensitization of the vestibular-autonomic reflex. This is the physiologic basis behind vestibular rehabilitation and why sailors eventually "get their sea legs."

2. Classification and Clinical Manifestation

Motion sickness does not have a formal staging system, but the progression of symptoms follows a predictable sequence that is useful for exam purposes:

Phase	Symptoms	Mechanism
Prodromal (Early)	Yawning, increased salivation, pallor, stomach awareness ("queasiness"), drowsiness	Early autonomic activation via vagal stimulation
Nausea Phase	Progressive nausea, cold sweating, warmth sensation, mild dizziness	Escalating CTZ and vomiting center activation
Emetic Phase	Frank vomiting (may be repeated), retching, severe malaise	Full activation of the emetic reflex arc
Sopite Syndrome	Profound drowsiness, fatigue, apathy, mood changes, difficulty concentrating without prominent nausea	Variant presentation; often missed on exam. Driven by vestibular-cortical pathways rather than the classic emetic circuit

By Transport Type

Transport Type	Example	Key Feature
Land-based	Car, bus, train	Worsened by rear seating, reading, poor ventilation
Sea-based	Boats, ships	Most common and severe form; low-frequency vertical oscillation is the strongest trigger
Air-based	Airplane, helicopter	Turbulence-provoked; less common with modern stabilized flight
Visually induced (Pseudomotion)	Large-screen movies, VR headsets, simulator environments	No true vestibular input; the conflict is reversed (visual says motion, vestibular says still). Sometimes called "cybersickness"

The sopite syndrome deserves emphasis. A vignette describing a patient who becomes profoundly sleepy, apathetic, or cognitively dull during prolonged travel without prominent nausea may be testing your recognition of this underdiagnosed variant.

3. Diagnostic Workup

Test	Role	When to Order
Clinical history	Diagnostic standard	Always. The temporal relationship between passive motion exposure and symptom onset, followed by resolution after cessation, is sufficient
Neurological examination	Rule out central causes	If symptoms are atypical (persistent vertigo, nystagmus at rest, hearing loss, focal deficits)
Audiometry	Evaluate for inner ear pathology	If hearing loss is present
MRI Brain	Rule out posterior fossa lesion	If central signs are present (direction-changing nystagmus, inability to walk, severe persistent vertigo)
Electronystagmography (ENG)	Assess vestibular function	If considering peripheral vestibulopathy

Motion sickness is a clinical diagnosis. There is no confirmatory lab test, no imaging finding, and no biomarker. The diagnosis rests entirely on the history: symptom onset during passive motion and resolution when the motion stops.

The role of the workup is purely to exclude alternative diagnoses when the presentation does not fit. If a vignette describes nausea and dizziness during travel that resolves completely afterward with a normal neurological exam, the answer is motion sickness, and no further testing is needed. Ordering an MRI or labs in this context would be an incorrect "next best step."

However, if the stem includes red flags such as persistent vertigo after the motion has ceased, unilateral hearing loss, spontaneous nystagmus, or focal neurological findings, the diagnosis shifts away from motion sickness, and imaging (MRI of the posterior fossa) or formal vestibular testing becomes appropriate.

4. Management and Treatment

Approach	Agent	Dose and Route	Timing and Notes
First-line prophylaxis (long duration)	Scopolamine transdermal patch	1.5 mg patch behind the ear	Apply 4 hours before travel; effective for up to 72 hours. Replace every 3 days for prolonged exposure
Short-duration prophylaxis / Acute treatment	Dimenhydrinate	50-100 mg PO every 4-6 hours (adults); 1-1.5 mg/kg per dose in children	Take 30-60 minutes before travel. Max 400 mg/day in adults
Alternative antihistamine	Meclizine	25-50 mg PO once daily	Less sedating than dimenhydrinate. Take 1 hour before travel
Refractory / severe	Promethazine	25 mg PO or IM	Useful for severe cases; more sedation and risk of extrapyramidal symptoms
Non-pharmacologic	Behavioral strategies	N/A	Gaze fixation on horizon, sit in front seat or over the wing, ensure fresh air, avoid reading, avoid heavy meals before travel

Prophylaxis is the cornerstone. The single most tested management concept is that treatment should be given before symptom onset. Once vomiting has begun, oral agents are poorly absorbed, and the autonomic cascade is already in full effect. This is why the scopolamine patch, applied hours in advance, is the preferred agent for anticipated prolonged motion exposure (e.g., sea travel).

Scopolamine is a muscarinic (M1) antagonist that acts directly on the vestibular nuclei and the vomiting center. It is the most effective single agent for prevention. The patch is placed on the hairless area behind the ear to optimize transdermal absorption near the mastoid. Patients must wash hands after application to avoid inadvertent pupillary dilation (anisocoria) from touching their eyes. Side effects include dry mouth, urinary retention, blurred vision, and drowsiness. It is contraindicated in patients with narrow-angle glaucoma.

Dimenhydrinate and meclizine are first-generation H1 antihistamines that cross the blood-brain barrier and suppress the vestibular-emetic pathway. They are preferred for short trips or when scopolamine is not available. Their primary drawback is sedation, which is particularly relevant for drivers or operators of heavy machinery.

For children, dimenhydrinate is the standard pharmacologic choice, dosed by weight. Scopolamine patches are generally not recommended for children under 12 due to heightened sensitivity to anticholinergic effects.

Non-pharmacologic measures should always be recommended alongside or before medication. Sitting in the front seat of a car or over the wing of an airplane minimizes vestibular stimulation. Fixating the gaze on the distant horizon re-establishes visual-vestibular congruence and directly addresses the underlying conflict.

Ondansetron (a 5-HT3 antagonist) is a common distractor. While it is an excellent antiemetic for chemotherapy-induced or postoperative nausea, it has limited efficacy for motion sickness because the emetic pathway in motion sickness is driven primarily by muscarinic and histaminergic pathways, not serotonergic ones.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Looks Similar	Key Discriminator
Benign Paroxysmal Positional Vertigo (BPPV)	Episodic dizziness and nausea triggered by movement	BPPV is triggered by head position changes (rolling in bed, looking up), not by passive transportation. Positive Dix-Hallpike test with fatigable, torsional nystagmus. Symptoms last seconds to a minute per episode
Vestibular migraine	Episodic vertigo, nausea, motion sensitivity	Associated with headache, photophobia, phonophobia, or aura. Symptoms can occur without any motion stimulus. History of migraine is present
Meniere disease	Episodic vertigo with nausea and vomiting	Classic triad of fluctuating sensorineural hearing loss, tinnitus, and aural fullness. Episodes last 20 minutes to several hours and are not linked to travel
Labyrinthitis / Vestibular neuritis	Acute vertigo, nausea, vomiting	Continuous vertigo lasting days, not episodic. Often follows a viral illness. Nystagmus is spontaneous and unidirectional. Not temporally linked to motion exposure
Posterior fossa tumor	Progressive dizziness, nausea, vomiting	Persistent and worsening symptoms unrelated to motion. Focal findings such as gait ataxia, cranial nerve palsies, papilledema
Cyclic vomiting syndrome	Recurrent stereotyped episodes of vomiting, especially in children	Episodes are not motion-dependent. Often occur on waking, associated with migraine family history, and follow a cyclical pattern
Pregnancy (hyperemesis gravidarum)	Nausea and vomiting in a young woman	Nausea is persistent and not limited to travel. Positive pregnancy test. Symptoms worsen with certain smells and in the morning

6. Traps and High-Yield Pearls

The most common way students get motion sickness questions wrong falls into three categories.

First, choosing ondansetron as the treatment. This is the single most popular trap. Students associate nausea and vomiting with ondansetron because it is the go-to antiemetic in so many other contexts (postoperative, chemotherapy). But motion sickness operates through muscarinic and histaminergic pathways, not serotonergic ones. Ondansetron does not address the underlying neurotransmitter circuit and is not effective here. The correct choices are scopolamine (for prolonged prophylaxis) or dimenhydrinate/meclizine (for shorter duration).

Second, failing to recognize the timing principle. A vignette may describe a patient about to embark on a multi-day cruise and ask for the best preventive measure. The answer is the scopolamine patch applied 4 hours before departure. Students who select oral dimenhydrinate are not wrong pharmacologically, but they are choosing a less optimal agent for prolonged exposure. The test rewards understanding of duration of action and clinical context.

Third, missing the sopite variant. A question stem describing fatigue, drowsiness, and poor concentration during travel without prominent nausea may lead students toward depression, sleep disorders, or carbon monoxide exposure. The temporal link to passive motion and resolution afterward should redirect toward the sopite presentation of motion sickness.

The core competency being tested is the ability to connect a sensory mismatch mechanism to the correct pharmacologic target (anticholinergics and antihistamines over serotonin antagonists), apply prophylactic timing principles, and distinguish a benign, self-limiting condition from more serious vestibular or central pathology based on the presence or absence of red-flag features.

1e:["$","$L2d",null,{"article":{"id":"1bf85bbe-be5e-48bb-bbdc-892cf29468d7","title":"Mabuk Perjalanan","content":"$2e","category":"THT-KL","created_at":"2026-05-15T09:28:56.089323+00:00","status":"published","subcategory":null},"questionCount":2,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]